Snowball logo
logo
4553

Towa Pharmaceutical Co Ltd

4553 • TSE
¥3,565.00-¥60.00  (1.66%)
Estimate
P/E
33.5
EPS
106.56
Beta
-0.09
Growth
Revenue, YoY
9.56%
Net income, YoY
120.1%
FCF, YoY
-255.82%
Forecast
P/E (FWD)
8.7
EPS (FWD)
411.842
Dividends
Dividend yield
2.24%
Annual payout
¥80.00
Next ex. div date
March 29, 27
Payout
47.73%
Div.growth, 5y
12.7%
Dividend growth streak
1 year
Div.rating
About the company
Ticker
4553
ISIN
JP3623150004
Country
Japan
Sector (GICS)
Healthcare
Towa Pharmaceutical Co., Ltd., together with its subsidiaries, manufactures and sale ethical drugs in Japan. The company operates through two segments; Domestic and Overseas. It provides its products in the therapeutic areas of digestive system, nervous system, and allergic diseases, as well as vitamins, antibiotics, and oncology products, as well as provide formulations from tablets, capsules, injectable, patches, eye drops, and other products. The company also offers IT service related to healthcare; disease risk testing services; and sale of quasi drugs. In addition, it is involved in research and development and production of active pharmaceutical ingredients, intermediates, and support business; and planning, development and OEM manufacturing of health foods, pharmaceuticals, general foods, and other miscellaneous merchandizes. Towa Pharmaceutical Co., Ltd. was founded in 1951 and is headquartered in Kadoma, Japan.

Frequently asked questions

What sector does Towa Pharmaceutical Co Ltd (4553) operate in?

Towa Pharmaceutical Co Ltd belongs to the Healthcare sector and operates in the Drug Manufacturers - Specialty & Generic industry.

What is Towa Pharmaceutical Co Ltd (4553) current stock price?

As of the latest data, Towa Pharmaceutical Co Ltd stock price is ¥3,565, with a previous close of ¥3,625. Towa Pharmaceutical Co Ltd lost -¥60 in the last trading session, representing a -1.66% loss.

What is Towa Pharmaceutical Co Ltd (4553) current market capitalization?

Towa Pharmaceutical Co Ltd market cap is approximately 175.50 billion.

What is Towa Pharmaceutical Co Ltd (4553) Earnings Per Share (EPS)?

The trailing EPS is ¥107, and the forward EPS is ¥412.

What is Towa Pharmaceutical Co Ltd (4553) Price-to-Earnings (P/E) ratio?

Towa Pharmaceutical Co Ltd current P/E ratio is 33.46, with a forward P/E of 8.66.

What is Towa Pharmaceutical Co Ltd (4553) EBITDA?

Towa Pharmaceutical Co Ltd EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) is 11.58 billion.

Does Towa Pharmaceutical Co Ltd (4553) pay dividends?

Yes. Towa Pharmaceutical Co Ltd pays semiannual dividends with an annualized yield of 2.24% and an estimated annual payout of ¥80 per share.

When is the next ex-dividend date for Towa Pharmaceutical Co Ltd (4553)?

The next ex-dividend date is scheduled for March 29, 2027.

When is Towa Pharmaceutical Co Ltd (4553) next earnings report?

Towa Pharmaceutical Co Ltd is expected to release its next earnings report on September 30, 2026.

What is Towa Pharmaceutical Co Ltd (4553) beta (volatility) score?

Towa Pharmaceutical Co Ltd has a beta of -0.090, indicating lower volatility than the overall market.